Pasireotide vs Pentosan Polysulfate
Overview
Pasireotide is primarily a hormonal peptide, while Pentosan Polysulfate is used for healing & recovery.
This page compares Pasireotide and Pentosan Polysulfate across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Pasireotide | Pentosan Polysulfate | |
|---|---|---|
| Category | Hormonal | Healing & Recovery |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 0.6–0.9 mg SC twice daily (Cushing's disease, SC formulation) or 40–60 mg IM every 4 weeks (acromegaly, LAR); 10–40 mg IM every 4 weeks (Cushing's disease, LAR) | 300 mg |
| Frequency | Twice daily (SC formulation) or every 4 weeks (LAR formulation) | daily |
| Reported benefits | Reduction of cortisol hypersecretion in Cushing's disease, normalization of GH and IGF-1 in acromegaly, pituitary tumor volume reduction, improvement of clinical signs of hypercortisolism | Joint protection, cartilage health, anti-inflammatory, bladder health |
| Reported side effects | Hyperglycemia, new-onset or worsening diabetes mellitus, diarrhea, nausea, cholelithiasis, QT interval prolongation, bradycardia, hepatic enzyme elevation, adrenal insufficiency (hypocortisolism) | Possible GI upset, hair loss (rare) |
Key differences
Primary use. Pasireotide is categorised under Hormonal, while Pentosan Polysulfate falls under Healing & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Pasireotide: FDA-approved. Pentosan Polysulfate: FDA-approved.
Dosing. Pasireotide is typically dosed at 0.6–0.9 mg SC twice daily (Cushing's disease, SC formulation) or 40–60 mg IM every 4 weeks (acromegaly, LAR); 10–40 mg IM every 4 weeks (Cushing's disease, LAR) (Twice daily (SC formulation) or every 4 weeks (LAR formulation)). Pentosan Polysulfate is typically dosed at 300 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Pasireotide and Pentosan Polysulfate has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Pasireotide and Pentosan Polysulfate?
- Pasireotide is primarily a hormonal peptide, while Pentosan Polysulfate is used for healing & recovery. Pasireotide is FDA-approved for one or more indications, whereas Pentosan Polysulfate is FDA-approved for one or more indications.
- What is Pasireotide used for?
- Multi-receptor somatostatin analog (Signifor/Signifor LAR) FDA-approved for Cushing's disease and acromegaly.
- What is Pentosan Polysulfate used for?
- FDA-approved oral drug (ELMIRON) for bladder pain of interstitial cystitis; joint uses are investigational.
- Can you take Pasireotide and Pentosan Polysulfate together?
- Some users combine peptides within a single protocol, but stacking Pasireotide and Pentosan Polysulfate has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Pasireotide or Pentosan Polysulfate FDA-approved?
- Pasireotide is FDA-approved for one or more indications. Pentosan Polysulfate is FDA-approved for one or more indications.
Read the full articles
- Pasireotide — full monograph: mechanism, research, dosing & references
- Pentosan Polysulfate — full monograph: mechanism, research, dosing & references